About
Praxis Precision Medicines, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 4 2026
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
Apr 14 2026
Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor
Apr 13 2026
Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026
Apr 6 2026
Praxis Precision Medicines Announces Positive Results from the EMBRAVE Part A Trial of Elsunersen in Patients with SCN2A Early-Onset Developmental and Epileptic Encephalopathy
Google Übersetzer